25 XP   0   0   10

CSPC Innovation Pharmaceutical Co Ltd Class A
Buy, Hold or Sell?

Let's analyse CSPC Innovation Pharmaceutical Co Ltd Class A together

PenkeI guess you are interested in CSPC Innovation Pharmaceutical Co Ltd Class A. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of CSPC Innovation Pharmaceutical Co Ltd Class A. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about CSPC Innovation Pharmaceutical Co Ltd Class A

I send you an email if I find something interesting about CSPC Innovation Pharmaceutical Co Ltd Class A.

Quick analysis of CSPC Innovation Pharmaceutical Co Ltd Class A (30 sec.)










What can you expect buying and holding a share of CSPC Innovation Pharmaceutical Co Ltd Class A? (30 sec.)

How much money do you get?

How much money do you get?
¥0.01
When do you have the money?
1 year
How often do you get paid?
95.0%

What is your share worth?

Current worth
¥4.35
Expected worth in 1 year
¥5.32
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥1.06
Return On Investment
3.2%

For what price can you sell your share?

Current Price per Share
¥33.63
Expected price per share
¥15.79 - ¥48.74
How sure are you?
50%

1. Valuation of CSPC Innovation Pharmaceutical Co Ltd Class A (5 min.)




Live pricePrice per Share (EOD)

¥33.63

Intrinsic Value Per Share

¥10.84 - ¥12.88

Total Value Per Share

¥15.19 - ¥17.23

2. Growth of CSPC Innovation Pharmaceutical Co Ltd Class A (5 min.)




Is CSPC Innovation Pharmaceutical Co Ltd Class A growing?

Current yearPrevious yearGrowGrow %
How rich?$702m$467.1m$200.7m30.1%

How much money is CSPC Innovation Pharmaceutical Co Ltd Class A making?

Current yearPrevious yearGrowGrow %
Making money$26m$25m$1m3.9%
Net Profit Margin30.3%28.3%--

How much money comes from the company's main activities?

3. Financial Health of CSPC Innovation Pharmaceutical Co Ltd Class A (5 min.)




4. Comparing to competitors in the Packaged Foods industry (5 min.)




  Industry Rankings (Packaged Foods)  


Richest
#128 / 493

Most Revenue
#304 / 493

Most Profit
#133 / 493

What can you expect buying and holding a share of CSPC Innovation Pharmaceutical Co Ltd Class A? (5 min.)

Welcome investor! CSPC Innovation Pharmaceutical Co Ltd Class A's management wants to use your money to grow the business. In return you get a share of CSPC Innovation Pharmaceutical Co Ltd Class A.

What can you expect buying and holding a share of CSPC Innovation Pharmaceutical Co Ltd Class A?

First you should know what it really means to hold a share of CSPC Innovation Pharmaceutical Co Ltd Class A. And how you can make/lose money.

Speculation

The Price per Share of CSPC Innovation Pharmaceutical Co Ltd Class A is ¥33.63. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of CSPC Innovation Pharmaceutical Co Ltd Class A.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in CSPC Innovation Pharmaceutical Co Ltd Class A, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥4.35. Based on the TTM, the Book Value Change Per Share is ¥0.24 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.21 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.02 per quarter.
Based on historical numbers we can estimate the returns while holding a share of CSPC Innovation Pharmaceutical Co Ltd Class A.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.020.1%0.020.1%0.020.1%0.010.0%0.010.0%
Usd Book Value Change Per Share0.020.1%0.030.1%0.030.1%0.030.1%0.030.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.020.1%0.040.1%0.030.1%0.030.1%0.030.1%
Usd Price Per Share5.05-3.09-2.06-3.33-3.33-
Price to Earnings Ratio62.29-35.92-26.42-83.02-83.02-
Price-to-Total Gains Ratio255.18-121.16-78.42-223.52-223.52-
Price to Book Ratio8.43-5.36-5.19-10.01-10.01-
Price-to-Total Gains Ratio255.18-121.16-78.42-223.52-223.52-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.64094
Number of shares215
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.030.03
Usd Total Gains Per Share0.040.03
Gains per Quarter (215 shares)7.867.27
Gains per Year (215 shares)31.4529.09
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
12292132619
25585275248
378783107777
41011611413103106
51214514517129135
61517417620155164
71720320723180193
82023223826206222
92226126930232251
102529030033258280

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%20.00.00.0100.0%20.00.00.0100.0%
Book Value Change Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%20.00.00.0100.0%20.00.00.0100.0%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%19.00.01.095.0%19.00.01.095.0%19.00.01.095.0%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%20.00.00.0100.0%20.00.00.0100.0%

Fundamentals of CSPC Innovation Pharmaceutical Co Ltd Class A

About CSPC Innovation Pharmaceutical Co Ltd Class A

CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of functional foods in the field of general health in China and internationally. It offers functional raw materials, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dyphylline, theobromine, pentoxifylline, doxofylline, and biological enzymes; and health food products, such as Guoweikangwei C tablets, Guoweikang B vitamin lozenges, etc. The company was founded in 2006 and is headquartered in Shijiazhuang, China. CSPC Innovation Pharmaceutical Co., Ltd. is a subsidiary of CSPC NBP Pharmaceutical Co., Ltd.

Fundamental data was last updated by Penke on 2024-04-23 08:32:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is fair priced.

1.1. Profitability of CSPC Innovation Pharmaceutical Co Ltd Class A.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit CSPC Innovation Pharmaceutical Co Ltd Class A earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare CSPC Innovation Pharmaceutical Co Ltd Class A to the Packaged Foods industry mean.
  • A Net Profit Margin of 28.7% means that ¥0.29 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of CSPC Innovation Pharmaceutical Co Ltd Class A:

  • The MRQ is 28.7%. The company is making a huge profit. +2
  • The TTM is 30.3%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ28.7%TTM30.3%-1.6%
TTM30.3%YOY28.3%+2.0%
TTM30.3%5Y25.0%+5.2%
5Y25.0%10Y25.0%0.0%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ28.7%3.0%+25.7%
TTM30.3%2.9%+27.4%
YOY28.3%2.9%+25.4%
5Y25.0%3.2%+21.8%
10Y25.0%3.6%+21.4%
1.1.2. Return on Assets

Shows how efficient CSPC Innovation Pharmaceutical Co Ltd Class A is using its assets to generate profit.

  • Above 5% is considered healthy but always compare CSPC Innovation Pharmaceutical Co Ltd Class A to the Packaged Foods industry mean.
  • 3.1% Return on Assets means that CSPC Innovation Pharmaceutical Co Ltd Class A generated ¥0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of CSPC Innovation Pharmaceutical Co Ltd Class A:

  • The MRQ is 3.1%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.5%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.1%TTM3.5%-0.5%
TTM3.5%YOY4.7%-1.2%
TTM3.5%5Y3.2%+0.3%
5Y3.2%10Y3.2%0.0%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ3.1%1.3%+1.8%
TTM3.5%1.3%+2.2%
YOY4.7%1.3%+3.4%
5Y3.2%1.4%+1.8%
10Y3.2%1.6%+1.6%
1.1.3. Return on Equity

Shows how efficient CSPC Innovation Pharmaceutical Co Ltd Class A is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare CSPC Innovation Pharmaceutical Co Ltd Class A to the Packaged Foods industry mean.
  • 3.4% Return on Equity means CSPC Innovation Pharmaceutical Co Ltd Class A generated ¥0.03 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of CSPC Innovation Pharmaceutical Co Ltd Class A:

  • The MRQ is 3.4%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.9%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.4%TTM3.9%-0.5%
TTM3.9%YOY5.3%-1.4%
TTM3.9%5Y3.6%+0.3%
5Y3.6%10Y3.6%0.0%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ3.4%2.8%+0.6%
TTM3.9%2.7%+1.2%
YOY5.3%3.0%+2.3%
5Y3.6%2.9%+0.7%
10Y3.6%3.0%+0.6%

1.2. Operating Efficiency of CSPC Innovation Pharmaceutical Co Ltd Class A.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient CSPC Innovation Pharmaceutical Co Ltd Class A is operating .

  • Measures how much profit CSPC Innovation Pharmaceutical Co Ltd Class A makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare CSPC Innovation Pharmaceutical Co Ltd Class A to the Packaged Foods industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of CSPC Innovation Pharmaceutical Co Ltd Class A:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM16.0%-16.0%
TTM16.0%YOY29.4%-13.3%
TTM16.0%5Y24.2%-8.2%
5Y24.2%10Y24.2%0.0%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.1%-5.1%
TTM16.0%3.6%+12.4%
YOY29.4%4.9%+24.5%
5Y24.2%5.1%+19.1%
10Y24.2%5.1%+19.1%
1.2.2. Operating Ratio

Measures how efficient CSPC Innovation Pharmaceutical Co Ltd Class A is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Packaged Foods industry mean).
  • An Operation Ratio of 1.31 means that the operating costs are ¥1.31 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of CSPC Innovation Pharmaceutical Co Ltd Class A:

  • The MRQ is 1.312. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.234. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.312TTM1.234+0.078
TTM1.234YOY1.252-0.018
TTM1.2345Y1.237-0.002
5Y1.23710Y1.2370.000
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3121.552-0.240
TTM1.2341.503-0.269
YOY1.2521.451-0.199
5Y1.2371.392-0.155
10Y1.2371.257-0.020

1.3. Liquidity of CSPC Innovation Pharmaceutical Co Ltd Class A.

1.3. Liquidity
1.3.1. Current Ratio

Measures if CSPC Innovation Pharmaceutical Co Ltd Class A is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Packaged Foods industry mean).
  • A Current Ratio of 8.26 means the company has ¥8.26 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of CSPC Innovation Pharmaceutical Co Ltd Class A:

  • The MRQ is 8.261. The company is very able to pay all its short-term debts. +2
  • The TTM is 8.290. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ8.261TTM8.290-0.030
TTM8.290YOY8.598-0.308
TTM8.2905Y7.803+0.487
5Y7.80310Y7.8030.000
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ8.2611.554+6.707
TTM8.2901.606+6.684
YOY8.5981.604+6.994
5Y7.8031.636+6.167
10Y7.8031.611+6.192
1.3.2. Quick Ratio

Measures if CSPC Innovation Pharmaceutical Co Ltd Class A is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare CSPC Innovation Pharmaceutical Co Ltd Class A to the Packaged Foods industry mean.
  • A Quick Ratio of 0.77 means the company can pay off ¥0.77 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of CSPC Innovation Pharmaceutical Co Ltd Class A:

  • The MRQ is 0.768. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.872. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.768TTM0.872-0.104
TTM0.872YOY2.261-1.389
TTM0.8725Y2.488-1.616
5Y2.48810Y2.4880.000
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7680.548+0.220
TTM0.8720.573+0.299
YOY2.2610.613+1.648
5Y2.4880.692+1.796
10Y2.4880.726+1.762

1.4. Solvency of CSPC Innovation Pharmaceutical Co Ltd Class A.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of CSPC Innovation Pharmaceutical Co Ltd Class A assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare CSPC Innovation Pharmaceutical Co Ltd Class A to Packaged Foods industry mean.
  • A Debt to Asset Ratio of 0.10 means that CSPC Innovation Pharmaceutical Co Ltd Class A assets are financed with 9.7% credit (debt) and the remaining percentage (100% - 9.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of CSPC Innovation Pharmaceutical Co Ltd Class A:

  • The MRQ is 0.097. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.099. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.097TTM0.099-0.002
TTM0.099YOY0.0990.000
TTM0.0995Y0.107-0.009
5Y0.10710Y0.1070.000
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0970.485-0.388
TTM0.0990.490-0.391
YOY0.0990.481-0.382
5Y0.1070.483-0.376
10Y0.1070.489-0.382
1.4.2. Debt to Equity Ratio

Measures if CSPC Innovation Pharmaceutical Co Ltd Class A is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare CSPC Innovation Pharmaceutical Co Ltd Class A to the Packaged Foods industry mean.
  • A Debt to Equity ratio of 10.7% means that company has ¥0.11 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of CSPC Innovation Pharmaceutical Co Ltd Class A:

  • The MRQ is 0.107. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.110. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.107TTM0.110-0.002
TTM0.110YOY0.111-0.001
TTM0.1105Y0.122-0.012
5Y0.12210Y0.1220.000
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1070.959-0.852
TTM0.1100.976-0.866
YOY0.1110.935-0.824
5Y0.1220.996-0.874
10Y0.1221.075-0.953

2. Market Valuation of CSPC Innovation Pharmaceutical Co Ltd Class A

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings CSPC Innovation Pharmaceutical Co Ltd Class A generates.

  • Above 15 is considered overpriced but always compare CSPC Innovation Pharmaceutical Co Ltd Class A to the Packaged Foods industry mean.
  • A PE ratio of 62.29 means the investor is paying ¥62.29 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of CSPC Innovation Pharmaceutical Co Ltd Class A:

  • The EOD is 57.200. Based on the earnings, the company is expensive. -2
  • The MRQ is 62.285. Based on the earnings, the company is expensive. -2
  • The TTM is 35.919. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD57.200MRQ62.285-5.086
MRQ62.285TTM35.919+26.366
TTM35.919YOY26.418+9.501
TTM35.9195Y83.019-47.100
5Y83.01910Y83.0190.000
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
EOD57.20013.646+43.554
MRQ62.28512.860+49.425
TTM35.91913.975+21.944
YOY26.41812.937+13.481
5Y83.01916.287+66.732
10Y83.01918.930+64.089
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of CSPC Innovation Pharmaceutical Co Ltd Class A:

  • The EOD is 40.321. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 43.906. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 33.496. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD40.321MRQ43.906-3.585
MRQ43.906TTM33.496+10.411
TTM33.496YOY42.526-9.030
TTM33.4965Y102.507-69.011
5Y102.50710Y102.5070.000
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
EOD40.3213.523+36.798
MRQ43.9063.344+40.562
TTM33.4961.746+31.750
YOY42.5260.147+42.379
5Y102.5071.627+100.880
10Y102.5071.610+100.897
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of CSPC Innovation Pharmaceutical Co Ltd Class A is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Packaged Foods industry mean).
  • A PB ratio of 8.43 means the investor is paying ¥8.43 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of CSPC Innovation Pharmaceutical Co Ltd Class A:

  • The EOD is 7.739. Based on the equity, the company is overpriced. -1
  • The MRQ is 8.428. Based on the equity, the company is overpriced. -1
  • The TTM is 5.362. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD7.739MRQ8.428-0.688
MRQ8.428TTM5.362+3.066
TTM5.362YOY5.189+0.173
TTM5.3625Y10.011-4.649
5Y10.01110Y10.0110.000
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
EOD7.7391.461+6.278
MRQ8.4281.462+6.966
TTM5.3621.457+3.905
YOY5.1891.742+3.447
5Y10.0111.848+8.163
10Y10.0112.378+7.633
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of CSPC Innovation Pharmaceutical Co Ltd Class A compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1430.244-41%0.210-32%0.217-34%0.217-34%
Book Value Per Share--4.3454.134+5%2.891+50%2.732+59%2.732+59%
Current Ratio--8.2618.2900%8.598-4%7.803+6%7.803+6%
Debt To Asset Ratio--0.0970.099-2%0.099-2%0.107-10%0.107-10%
Debt To Equity Ratio--0.1070.110-2%0.111-3%0.122-12%0.122-12%
Dividend Per Share--0.0000.021-99%0.035-100%0.028-100%0.028-100%
Eps--0.1470.161-9%0.155-5%0.101+45%0.101+45%
Free Cash Flow Per Share--0.2090.178+17%0.112+85%0.081+157%0.081+157%
Free Cash Flow To Equity Per Share--0.2090.178+17%0.099+111%0.069+203%0.069+203%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--12.882--------
Intrinsic Value_10Y_min--10.843--------
Intrinsic Value_1Y_max--0.544--------
Intrinsic Value_1Y_min--0.533--------
Intrinsic Value_3Y_max--2.203--------
Intrinsic Value_3Y_min--2.091--------
Intrinsic Value_5Y_max--4.549--------
Intrinsic Value_5Y_min--4.173--------
Market Cap39371985123.840-9%42872577679.48026189501984.980+64%17444025523.200+146%28235898767.289+52%28235898767.289+52%
Net Profit Margin--0.2870.303-5%0.283+2%0.250+15%0.250+15%
Operating Margin---0.160-100%0.294-100%0.242-100%0.242-100%
Operating Ratio--1.3121.234+6%1.252+5%1.237+6%1.237+6%
Pb Ratio7.739-9%8.4285.362+57%5.189+62%10.011-16%10.011-16%
Pe Ratio57.200-9%62.28535.919+73%26.418+136%83.019-25%83.019-25%
Price Per Share33.630-9%36.62022.370+64%14.900+146%24.118+52%24.118+52%
Price To Free Cash Flow Ratio40.321-9%43.90633.496+31%42.526+3%102.507-57%102.507-57%
Price To Total Gains Ratio234.346-9%255.181121.160+111%78.421+225%223.524+14%223.524+14%
Quick Ratio--0.7680.872-12%2.261-66%2.488-69%2.488-69%
Return On Assets--0.0310.035-13%0.047-35%0.032-4%0.032-4%
Return On Equity--0.0340.039-14%0.053-36%0.036-5%0.036-5%
Total Gains Per Share--0.1440.265-46%0.245-41%0.245-41%0.245-41%
Usd Book Value--702028416.231667850687.759+5%467147084.363+50%441318058.804+59%441318058.804+59%
Usd Book Value Change Per Share--0.0200.034-41%0.029-32%0.030-34%0.030-34%
Usd Book Value Per Share--0.6000.570+5%0.399+50%0.377+59%0.377+59%
Usd Dividend Per Share--0.0000.003-99%0.005-100%0.004-100%0.004-100%
Usd Eps--0.0200.022-9%0.021-5%0.014+45%0.014+45%
Usd Free Cash Flow--33687662.99028687084.352+17%18170028.307+85%13127007.853+157%13127007.853+157%
Usd Free Cash Flow Per Share--0.0290.025+17%0.016+85%0.011+157%0.011+157%
Usd Free Cash Flow To Equity Per Share--0.0290.025+17%0.014+111%0.010+203%0.010+203%
Usd Market Cap5433333947.090-9%5916415719.7683614151273.927+64%2407275522.202+146%3896554029.886+52%3896554029.886+52%
Usd Price Per Share4.641-9%5.0543.087+64%2.056+146%3.328+52%3.328+52%
Usd Profit--23747184.04326066725.238-9%25056587.273-5%16366382.269+45%16366382.269+45%
Usd Revenue--82776310.72886308646.755-4%90613864.726-9%63025240.906+31%63025240.906+31%
Usd Total Gains Per Share--0.0200.037-46%0.034-41%0.034-41%0.034-41%
 EOD+4 -4MRQTTM+14 -21YOY+15 -205Y+23 -1210Y+23 -12

3.2. Fundamental Score

Let's check the fundamental score of CSPC Innovation Pharmaceutical Co Ltd Class A based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1557.200
Price to Book Ratio (EOD)Between0-17.739
Net Profit Margin (MRQ)Greater than00.287
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.768
Current Ratio (MRQ)Greater than18.261
Debt to Asset Ratio (MRQ)Less than10.097
Debt to Equity Ratio (MRQ)Less than10.107
Return on Equity (MRQ)Greater than0.150.034
Return on Assets (MRQ)Greater than0.050.031
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of CSPC Innovation Pharmaceutical Co Ltd Class A based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.682
Ma 20Greater thanMa 5036.590
Ma 50Greater thanMa 10035.570
Ma 100Greater thanMa 20035.678
OpenGreater thanClose33.010
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Interest Expense  199-14185-5180-55125-260-135



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets5,632,124
Total Liabilities544,961
Total Stockholder Equity5,078,809
 As reported
Total Liabilities 544,961
Total Stockholder Equity+ 5,078,809
Total Assets = 5,632,124

Assets

Total Assets5,632,124
Total Current Assets4,219,882
Long-term Assets1,412,242
Total Current Assets
Cash And Cash Equivalents 3,422,173
Net Receivables 392,376
Inventory 223,685
Other Current Assets 10,882
Total Current Assets  (as reported)4,219,882
Total Current Assets  (calculated)4,049,116
+/- 170,766
Long-term Assets
Property Plant Equipment 1,059,175
Intangible Assets 48,031
Long-term Assets Other 20,607
Long-term Assets  (as reported)1,412,242
Long-term Assets  (calculated)1,127,813
+/- 284,429

Liabilities & Shareholders' Equity

Total Current Liabilities510,838
Long-term Liabilities34,123
Total Stockholder Equity5,078,809
Total Current Liabilities
Accounts payable 173,684
Other Current Liabilities 2,260
Total Current Liabilities  (as reported)510,838
Total Current Liabilities  (calculated)175,944
+/- 334,895
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt841
Long-term Liabilities  (as reported)34,123
Long-term Liabilities  (calculated)841
+/- 33,282
Total Stockholder Equity
Retained Earnings 2,552,591
Total Stockholder Equity (as reported)5,078,809
Total Stockholder Equity (calculated)2,552,591
+/- 2,526,218
Other
Capital Stock1,170,742
Common Stock Shares Outstanding 1,170,742
Net Invested Capital 5,078,809
Net Working Capital 3,709,044
Property Plant and Equipment Gross 1,059,175



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
2,584,447
2,655,258
2,669,652
2,852,373
2,917,822
2,918,361
2,948,519
2,954,903
3,057,642
3,059,106
3,127,646
3,225,776
3,350,339
3,472,192
3,670,308
4,584,036
5,180,768
5,276,732
5,383,748
5,632,124
5,632,1245,383,7485,276,7325,180,7684,584,0363,670,3083,472,1923,350,3393,225,7763,127,6463,059,1063,057,6422,954,9032,948,5192,918,3612,917,8222,852,3732,669,6522,655,2582,584,447
   > Total Current Assets 
1,850,334
1,916,551
1,934,383
1,937,017
1,995,192
1,964,519
1,901,349
1,913,048
2,144,945
2,145,011
2,222,274
2,317,964
2,446,419
2,535,536
2,730,006
3,190,593
3,803,862
3,882,116
4,002,372
4,219,882
4,219,8824,002,3723,882,1163,803,8623,190,5932,730,0062,535,5362,446,4192,317,9642,222,2742,145,0112,144,9451,913,0481,901,3491,964,5191,995,1921,937,0171,934,3831,916,5511,850,334
       Cash And Cash Equivalents 
1,340,102
377,313
381,137
475,142
1,202,508
496,672
573,841
1,138,745
1,292,695
1,265,337
1,348,059
1,231,863
1,702,760
1,464,047
1,610,322
2,195,684
2,802,093
2,899,822
3,166,277
3,422,173
3,422,1733,166,2772,899,8222,802,0932,195,6841,610,3221,464,0471,702,7601,231,8631,348,0591,265,3371,292,6951,138,745573,841496,6721,202,508475,142381,137377,3131,340,102
       Short-term Investments 
0
1,004,501
1,008,336
960,086
270,877
956,598
830,117
321,943
323,933
322,327
312,190
413,594
0
300,778
301,284
0
0
0
0
0
00000301,284300,7780413,594312,190322,327323,933321,943830,117956,598270,877960,0861,008,3361,004,5010
       Net Receivables 
194,419
185,637
177,157
351,237
376,000
366,915
361,775
305,757
356,340
370,326
346,617
412,862
439,768
515,209
552,298
718,313
439,056
451,542
393,116
392,376
392,376393,116451,542439,056718,313552,298515,209439,768412,862346,617370,326356,340305,757361,775366,915376,000351,237177,157185,637194,419
       Inventory 
126,709
124,154
147,955
124,231
119,780
110,261
96,982
110,999
140,963
149,736
173,762
216,857
261,688
210,966
208,904
238,126
229,119
223,913
253,075
223,685
223,685253,075223,913229,119238,126208,904210,966261,688216,857173,762149,736140,963110,99996,982110,261119,780124,231147,955124,154126,709
       Other Current Assets 
15,451
20,987
21,427
26,322
26,028
34,073
38,635
35,604
31,014
37,285
41,647
42,788
42,203
44,536
57,199
38,470
13,825
17,012
7,106
10,882
10,8827,10617,01213,82538,47057,19944,53642,20342,78841,64737,28531,01435,60438,63534,07326,02826,32221,42720,98715,451
   > Long-term Assets 
734,113
738,706
735,269
915,356
922,630
953,842
1,047,170
1,041,855
912,697
914,096
905,372
907,812
903,920
936,656
940,302
1,393,443
1,376,906
1,394,617
1,381,377
1,412,242
1,412,2421,381,3771,394,6171,376,9061,393,443940,302936,656903,920907,812905,372914,096912,6971,041,8551,047,170953,842922,630915,356735,269738,706734,113
       Property Plant Equipment 
650,980
657,337
655,558
678,170
671,804
696,440
724,709
727,486
613,468
610,686
602,895
595,648
588,131
622,078
619,678
1,054,753
1,044,351
1,055,621
1,051,508
1,059,175
1,059,1751,051,5081,055,6211,044,3511,054,753619,678622,078588,131595,648602,895610,686613,468727,486724,709696,440671,804678,170655,558657,337650,980
       Goodwill 
3,468
3,468
3,468
3,468
3,468
3,468
3,468
3,468
3,468
3,468
3,468
0
0
0
0
0
0
0
0
0
0000000003,4683,4683,4683,4683,4683,4683,4683,4683,4683,4683,468
       Intangible Assets 
59,336
58,746
58,157
57,567
56,977
56,387
55,797
55,207
43,578
43,073
42,569
42,417
41,888
41,363
40,841
50,419
49,822
49,234
48,624
48,031
48,03148,62449,23449,82250,41940,84141,36341,88842,41742,56943,07343,57855,20755,79756,38756,97757,56758,15758,74659,336
       Other Assets 
20,330
19,155
18,087
19,866
34,028
39,148
27,795
19,819
17,286
20,807
20,904
26,561
31,459
30,177
35,763
34,781
0
0
0
0
000034,78135,76330,17731,45926,56120,90420,80717,28619,81927,79539,14834,02819,86618,08719,15520,330
> Total Liabilities 
386,233
376,366
314,433
437,062
429,429
351,471
304,398
268,003
287,679
251,399
238,941
265,438
278,685
290,733
327,120
639,841
566,568
539,414
464,439
544,961
544,961464,439539,414566,568639,841327,120290,733278,685265,438238,941251,399287,679268,003304,398351,471429,429437,062314,433376,366386,233
   > Total Current Liabilities 
344,703
336,363
276,709
400,758
394,220
315,900
268,899
234,242
252,967
218,337
206,489
231,040
246,324
259,419
296,323
582,768
509,764
482,148
426,352
510,838
510,838426,352482,148509,764582,768296,323259,419246,324231,040206,489218,337252,967234,242268,899315,900394,220400,758276,709336,363344,703
       Short-term Debt 
20,201
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000020,201
       Short Long Term Debt 
20,201
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000020,201
       Accounts payable 
83,935
97,613
85,512
92,703
70,141
64,663
62,697
64,158
80,565
62,254
66,179
68,852
59,517
46,233
66,515
178,750
145,007
137,597
82,819
173,684
173,68482,819137,597145,007178,75066,51546,23359,51768,85266,17962,25480,56564,15862,69764,66370,14192,70385,51297,61383,935
       Other Current Liabilities 
50,000
50,000
181,574
284,447
310,816
217,858
191,536
145,828
159,225
108,317
126,841
118,993
171,893
170,085
211,720
337,554
4,297
278,416
2,237
2,260
2,2602,237278,4164,297337,554211,720170,085171,893118,993126,841108,317159,225145,828191,536217,858310,816284,447181,57450,00050,000
   > Long-term Liabilities 
41,529
40,003
37,724
36,304
35,209
35,571
35,499
33,761
34,713
33,062
32,452
34,398
32,360
31,315
30,797
57,073
56,804
57,265
38,086
34,123
34,12338,08657,26556,80457,07330,79731,31532,36034,39832,45233,06234,71333,76135,49935,57135,20936,30437,72440,00341,529
       Other Liabilities 
41,529
40,003
37,724
36,304
35,209
35,571
35,499
33,761
33,264
32,637
32,221
34,398
32,360
31,315
30,797
37,273
0
0
0
0
000037,27330,79731,31532,36034,39832,22132,63733,26433,76135,49935,57135,20936,30437,72440,00341,529
> Total Stockholder Equity
2,189,625
2,270,170
2,346,407
2,406,400
2,479,437
2,557,972
2,635,189
2,678,112
2,761,509
2,799,218
2,880,099
2,952,079
3,063,413
3,172,998
3,334,608
3,935,601
4,605,653
4,728,545
4,910,688
5,078,809
5,078,8094,910,6884,728,5454,605,6533,935,6013,334,6083,172,9983,063,4132,952,0792,880,0992,799,2182,761,5092,678,1122,635,1892,557,9722,479,4372,406,4002,346,4072,270,1702,189,625
   Common Stock
200,000
200,000
200,000
200,000
200,000
420,000
420,000
420,000
420,000
546,000
546,000
546,000
546,000
546,000
546,000
618,926
0
0
0
0
0000618,926546,000546,000546,000546,000546,000546,000420,000420,000420,000420,000200,000200,000200,000200,000200,000
   Retained Earnings 
798,699
879,239
955,572
1,104,098
1,177,223
1,255,584
1,333,283
1,375,933
1,459,462
1,497,404
1,578,382
1,651,005
1,761,997
1,871,476
2,031,720
2,177,484
2,137,529
2,224,049
2,322,817
2,552,591
2,552,5912,322,8172,224,0492,137,5292,177,4842,031,7201,871,4761,761,9971,651,0051,578,3821,497,4041,459,4621,375,9331,333,2831,255,5841,177,2231,104,098955,572879,239798,699
   Capital Surplus 00000000000000000000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 
0
6
-90
26
-62
112
-371
-97
-229
-462
-560
-1,202
-861
-754
611
719
0
0
0
0
0000719611-754-861-1,202-560-462-229-97-371112-6226-9060



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue2,501,700
Cost of Revenue-1,367,653
Gross Profit1,134,0471,134,047
 
Operating Income (+$)
Gross Profit1,134,047
Operating Expense-1,718,577
Operating Income783,123-584,530
 
Operating Expense (+$)
Research Development46,542
Selling General Administrative231,595
Selling And Marketing Expenses0
Operating Expense1,718,577278,138
 
Net Interest Income (+$)
Interest Income65,900
Interest Expense-356
Other Finance Cost-284
Net Interest Income65,261
 
Pretax Income (+$)
Operating Income783,123
Net Interest Income65,261
Other Non-Operating Income Expenses0
Income Before Tax (EBT)891,787783,123
EBIT - interestExpense = -356
755,557
755,913
Interest Expense356
Earnings Before Interest and Taxes (EBIT)0892,143
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax891,787
Tax Provision-136,470
Net Income From Continuing Ops755,318755,318
Net Income755,557
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-65,261
 

Technical Analysis of CSPC Innovation Pharmaceutical Co Ltd Class A
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of CSPC Innovation Pharmaceutical Co Ltd Class A. The general trend of CSPC Innovation Pharmaceutical Co Ltd Class A is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine CSPC Innovation Pharmaceutical Co Ltd Class A's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of CSPC Innovation Pharmaceutical Co Ltd Class A.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 42.80 < 48.74.

The bearish price targets are: 23.63 > 21.25 > 15.79.

Tweet this
CSPC Innovation Pharmaceutical Co Ltd Class A Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of CSPC Innovation Pharmaceutical Co Ltd Class A. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

CSPC Innovation Pharmaceutical Co Ltd Class A Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of CSPC Innovation Pharmaceutical Co Ltd Class A. The current macd is -0.32760675.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the CSPC Innovation Pharmaceutical Co Ltd Class A price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for CSPC Innovation Pharmaceutical Co Ltd Class A. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the CSPC Innovation Pharmaceutical Co Ltd Class A price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
CSPC Innovation Pharmaceutical Co Ltd Class A Daily Moving Average Convergence/Divergence (MACD) ChartCSPC Innovation Pharmaceutical Co Ltd Class A Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of CSPC Innovation Pharmaceutical Co Ltd Class A. The current adx is 21.47.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell CSPC Innovation Pharmaceutical Co Ltd Class A shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
CSPC Innovation Pharmaceutical Co Ltd Class A Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of CSPC Innovation Pharmaceutical Co Ltd Class A. The current sar is 38.82.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
CSPC Innovation Pharmaceutical Co Ltd Class A Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of CSPC Innovation Pharmaceutical Co Ltd Class A. The current rsi is 40.68. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending up: The RSI is trending up. +1
CSPC Innovation Pharmaceutical Co Ltd Class A Daily Relative Strength Index (RSI) ChartCSPC Innovation Pharmaceutical Co Ltd Class A Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of CSPC Innovation Pharmaceutical Co Ltd Class A. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the CSPC Innovation Pharmaceutical Co Ltd Class A price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
CSPC Innovation Pharmaceutical Co Ltd Class A Daily Stochastic Oscillator ChartCSPC Innovation Pharmaceutical Co Ltd Class A Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of CSPC Innovation Pharmaceutical Co Ltd Class A. The current cci is -221.97705207.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
CSPC Innovation Pharmaceutical Co Ltd Class A Daily Commodity Channel Index (CCI) ChartCSPC Innovation Pharmaceutical Co Ltd Class A Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of CSPC Innovation Pharmaceutical Co Ltd Class A. The current cmo is -26.75910021.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
CSPC Innovation Pharmaceutical Co Ltd Class A Daily Chande Momentum Oscillator (CMO) ChartCSPC Innovation Pharmaceutical Co Ltd Class A Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of CSPC Innovation Pharmaceutical Co Ltd Class A. The current willr is -70.90163934.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that CSPC Innovation Pharmaceutical Co Ltd Class A is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
CSPC Innovation Pharmaceutical Co Ltd Class A Daily Williams %R ChartCSPC Innovation Pharmaceutical Co Ltd Class A Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of CSPC Innovation Pharmaceutical Co Ltd Class A.

CSPC Innovation Pharmaceutical Co Ltd Class A Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of CSPC Innovation Pharmaceutical Co Ltd Class A. The current atr is 2.22407096.

CSPC Innovation Pharmaceutical Co Ltd Class A Daily Average True Range (ATR) ChartCSPC Innovation Pharmaceutical Co Ltd Class A Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of CSPC Innovation Pharmaceutical Co Ltd Class A. The current obv is 678,542,317.

CSPC Innovation Pharmaceutical Co Ltd Class A Daily On-Balance Volume (OBV) ChartCSPC Innovation Pharmaceutical Co Ltd Class A Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of CSPC Innovation Pharmaceutical Co Ltd Class A. The current mfi is 42.71.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
CSPC Innovation Pharmaceutical Co Ltd Class A Daily Money Flow Index (MFI) ChartCSPC Innovation Pharmaceutical Co Ltd Class A Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for CSPC Innovation Pharmaceutical Co Ltd Class A.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-11-30BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-25STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-30MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-13MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

CSPC Innovation Pharmaceutical Co Ltd Class A Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of CSPC Innovation Pharmaceutical Co Ltd Class A based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.682
Ma 20Greater thanMa 5036.590
Ma 50Greater thanMa 10035.570
Ma 100Greater thanMa 20035.678
OpenGreater thanClose33.010
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of CSPC Innovation Pharmaceutical Co Ltd Class A with someone you think should read this too:
  • Are you bullish or bearish on CSPC Innovation Pharmaceutical Co Ltd Class A? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about CSPC Innovation Pharmaceutical Co Ltd Class A? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about CSPC Innovation Pharmaceutical Co Ltd Class A

I send you an email if I find something interesting about CSPC Innovation Pharmaceutical Co Ltd Class A.


Comments

How you think about this?

Leave a comment

Stay informed about CSPC Innovation Pharmaceutical Co Ltd Class A.

Receive notifications about CSPC Innovation Pharmaceutical Co Ltd Class A in your mailbox!